Defining the Risk of Early Recurrence Following Curative-Intent Resection for Distal Cholangiocarcinoma

Immunotherapy utilization for hepatobiliary cancer in the United States: disparities among patients with different socioeconomic status

(2020) Kota Sahara et al.   Hepatobiliary Surgery and Nutrition

Time to Recurrence After Surgical Resection and Survival After Recurrence Among Patients with Perihilar and Distal Cholangiocarcinomas

(2020) Yoshitsugu Nakanishi et al.   ANNALS OF SURGICAL ONCOLOGY

The Impact of Preoperative CA19-9 and CEA on Outcomes of Patients with Intrahepatic Cholangiocarcinoma

(2020) Amika Moro et al.   ANNALS OF SURGICAL ONCOLOGY

Neoadjuvant chemotherapy with gemcitabine plus cisplatin followed by radical liver resection versus immediate radical liver resection alone with or without adjuvant chemotherapy in incidentally detected gallbladder carcinoma after simple cholecystectomy or in front of radical resection of BTC (ICC/ECC) – a phase III study of the German registry of incidental gallbladder carcinoma platform (GR)– the AIO/ CALGP/ ACO- GAIN-trial –

(2020) Thorsten O. Goetze et al.   BMC CANCER

Prognostic factors and patterns of recurrence after curative resection for patients with distal cholangiocarcinoma

(2020) Weiwen Zhou et al.   RADIOTHERAPY AND ONCOLOGY

Very Early Recurrence After Liver Resection for Intrahepatic Cholangiocarcinoma

(2020) Diamantis I. Tsilimigras et al.   JAMA Surgery

Overall Tumor Burden Dictates Outcomes for Patients Undergoing Resection of Multinodular Hepatocellular Carcinoma Beyond the Milan Criteria

(2020) Diamantis I. Tsilimigras et al.   ANNALS OF SURGERY

ASO Author Reflections: Validated Prediction Model of Early Recurrence after Resection for Gallbladder Cancer: Identifying a Subset of Patients Who May be Better Served with Neoadjuvant Therapy

(2020) Kota Sahara et al.   ANNALS OF SURGICAL ONCOLOGY

Gemcitabine and Oxaliplatin Chemotherapy or Surveillance in Resected Biliary Tract Cancer (PRODIGE 12-ACCORD 18-UNICANCER GI): A Randomized Phase III Study

(2019) Julien Edeline et al.   JOURNAL OF CLINICAL ONCOLOGY

Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: A propensity score matched analysis

(2019) Siddhartha Yadav et al.   EJSO

Association of Perioperative Transfusion with Recurrence and Survival After Resection of Distal Cholangiocarcinoma: A 10-Institution Study from the US Extrahepatic Biliary Malignancy Consortium

(2019) Alexandra G. Lopez-Aguiar et al.   ANNALS OF SURGICAL ONCOLOGY

A Clinical Nomogram for Predicting Node-positive Disease in Esophageal Cancer

(2019) Tara R. Semenkovich et al.   ANNALS OF SURGERY

Optimal Pancreatic Surgery

(2019) Joal D. Beane et al.   ANNALS OF SURGERY

Correlation of Neutrophil to Lymphocyte Ratio and Absolute Neutrophil Count With Outcomes With PD-1 Axis Inhibitors in Patients With Advanced Non–Small-Cell Lung Cancer

(2018) Alona Zer et al.   Clinical Lung Cancer

Metroticket 2.0 Model for Analysis of Competing Risks of Death After Liver Transplantation for Hepatocellular Carcinoma

(2018) Vincenzo Mazzaferro et al.   GASTROENTEROLOGY

Outcome of neoadjuvant chemotherapy in “locally advanced/borderline resectable” gallbladder cancer: the need to define indications

(2018) Vikram A. Chaudhari et al.   HPB

Multicentre study of the impact of factors that may affect long-term survival following pancreaticoduodenectomy for distal cholangiocarcinoma

(2018) Laëtitia Courtin-Tanguy et al.   HPB

Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection

(2018) Anthony W.H. Chan et al.   JOURNAL OF HEPATOLOGY

Our Rationale of Initiating Neoadjuvant Chemotherapy for Hilar Cholangiocarcinoma: A Proposal of Criteria for “Borderline Resectable” in the Field of Surgery for Hilar Cholangiocarcinoma

(2018) Ryusei Matsuyama et al.   WORLD JOURNAL OF SURGERY

Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma

(2018) Xin-Fei Xu et al.   JAMA Surgery

Prognostic significance of neutrophil-to-lymphocyte ratio in biliary tract cancers: a systematic review and meta-analysis

(2017) Haowen Tang et al.   Oncotarget

Impact of Portal Vein Involvement from Pancreatic Cancer on Metastatic Pattern After Surgical Resection

(2016) Franz Mierke et al.   ANNALS OF SURGICAL ONCOLOGY

Neutrophil to lymphocyte ratio as an indicator of the malignant behaviour of hepatocellular carcinoma

(2016) Y. Okamura et al.   BRITISH JOURNAL OF SURGERY

Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells

(2011) Andrea Facciabene et al.   NATURE

Multiple Imputation for Missing Data: Fully Conditional Specification Versus Multivariate Normal Imputation

(2010) K. J. Lee et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Predictors of Survival in Periampullary Cancers Following Pancreaticoduodenectomy

(2010) Ioannis Hatzaras et al.   ANNALS OF SURGICAL ONCOLOGY

Negative Impact of Neutrophil-Lymphocyte Ratio on Outcome After Liver Transplantation for Hepatocellular Carcinoma

(2009) Karim J. Halazun et al.   ANNALS OF SURGERY

Prognosis of Resected Ampullary Adenocarcinoma by Preoperative Serum CA19-9 Levels and Platelet-Lymphocyte Ratio

(2008) Richard A. Smith et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Borderline Resectable Pancreatic Cancer: The Importance of This Emerging Stage of Disease

(2008) Matthew H.G. Katz et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

Prognostic factors in patients with advanced cholangiocarcinoma: Role of surgery, chemotherapy and body mass index

(2008) Mirna H Farhat et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases

(2007) K.J. Halazun et al.   EJSO